Benchling Raises $200M Series E to Accelerate Biotech R&D Read Now

Meet our customers

Nicholas Papadopoulos
SVP R&D Operations
“Since our founding, science has remained our central guiding principle. Benchling fits perfectly into this philosophy, providing us a flexible informatics platform that enables our scientists to focus on high-impact research and deliver life-transforming medicines.”

More than 300,000 scientists worldwide across pharma, biotech, and academia

  • Gilead Logo

    Gilead Sciences

    Gilead is dedicated to developing innovative medicines for life-threatening illnesses.
  • Sanofi logo

    Sanofi

    Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
  • Regeneron

    A leading biotechnology company using the power of science to bring new medicines to patients in need.
  • Zoetis

    Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways, delivering medicines, vaccines, and diagnostic products.
  • Ginkgo

    Ginkgo Bioworks is designing custom organisms for customers across multiple markets, learning from nature to replace technology with biology.
  • Mammoth Biosciences

    Mammoth Biosciences provides a CRISPR-based platform for disease detection across healthcare, agriculture, and other industries
  • Daiichi Sankyo Inc

    Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan.
  • Eisai

    Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.
  • BEAM Therapeutics

    Beam is pioneering the use of base editing — a potential new class of precision genetic medicines — with a vision of providing life-long cures to patients suffering from serious diseases.
  • BP Biosciences

    BP’s Biosciences Center conducts innovative research, supports strategic investments and manages academic partnerships designed to accelerate the global transition to a low-carbon future.
  • Jounce Therapeutics, Inc.

    Jounce is a clinical-stage immunotherapy company developing therapies that enable the immune system to attack tumors.
    Case Study
  • UCB

    UCB

    UCB focuses on making a difference for people living with severe diseases, with an emphasis on the areas of immunology and neurology.
  • Corteva logo

    Corteva Agriscience

    We provide agronomic support and services to help increase farmer productivity and profitability.
  • Arsenal Biosciences

    ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies.
  • Rubius

    Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines.
    Case Study
  • Kite Pharma

    Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer.
  • Zymergen

    Unlocking the power of biology to make strain optimization as reliable and predictable as other engineering processes.
    Case Study
  • SPOTLIGHT

    Spotlight Therapeutics

    We are creating next-generation programmable nucleases that can selectively edit specific cell populations directly in the body.
  • Pairwise

    Pairwise is bringing together leaders in agriculture and technology to harness the potential of genome editing to address consumers’ and farmers’ needs.
    Case Study
  • Editas

    A leading genome editing company dedicated to treating patients with genetically defined diseases.
  • Insitro

    insitro will integrate cutting-edge machine learning techniques with the innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets.
  • Bolt Threads

    Bolt Threads is bioengineering the next generation of fabrics and garments with their Microsilk and Mylo technologies.
    Case Study
  • Denali Therapeutics

    Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
  • Syngenta logo

    Syngenta

    We aim to improve the sustainability, quality and safety of agriculture with world class science and innovative crop solutions.
  • Sorrento

    Sorrento Therapeutics is a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possible curable diseases.
  • Lyell Immunopharma

    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality.
  • Sana Biotechnology

    Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease.
  • Synlogic

    Synlogic is working at the cross section of biology and engineering, advancing a new class of medicines for patients.
    Case Study
  • Adicet Bio

    Universal, off-the-shelf immune cell therapy for treatment of cancer and other diseases
    Case Study
  • New England Biolabs

    Recombinant and native enzyme reagents for life science research. Provides solutions supporting genome editing, synthetic biology and next-generation sequencing.
  • Agenus

    Using the power of the immune system to develop a broad range of innovative therapeutic antibody and vaccine candidates against cancer.
    Case Study
  • uniQure

    Delivering on the promise of gene therapy, single treatments with potentially curative results.
    Case Study
  • Obsidian Therapeutics

    Building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients.
    Case Study
  • TurtleTree Labs

    TurtleTree Labs is recreating the full composition, functionality and taste of milk using the latest cutting edge innovation in biotech.
    Case Study

Join over 300,000 scientists using
Benchling to power life science R&D